Medtronic (MDT) – Research Analysts’ Weekly Ratings Updates

Medtronic (NYSE: MDT) has recently received a number of price target changes and ratings updates:

• 1/30/2026 – Medtronic is now covered by analysts at CICC Research. They set an “outperform” rating on the stock.
• 1/30/2026 – Medtronic is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $114.00 price target on the stock.
• 1/23/2026 – Medtronic was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 1/9/2026 – Medtronic had its price target raised by analysts at Sanford C. Bernstein from $111.00 to $112.00. They now have an “outperform” rating on the stock.
• 1/8/2026 – Medtronic had its price target raised by analysts at Barclays PLC from $111.00 to $116.00. They now have an “overweight” rating on the stock.
• 1/6/2026 – Medtronic was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating.
• 1/5/2026 – Medtronic had its “neutral” rating reaffirmed by analysts at Piper Sandler.
• 1/3/2026 – Medtronic was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 12/29/2025 – Medtronic had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/20/2025 – Medtronic was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 12/18/2025 – Medtronic had its price target lowered by analysts at Truist Financial Corporation from $110.00 to $107.00. They now have a “hold” rating on the stock.
• 12/16/2025 – Medtronic was given a new $103.00 price target on by analysts at Robert W. Baird.
• 12/15/2025 – Medtronic had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Medtronic had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/6/2025 – Medtronic was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 12/2/2025 – Medtronic had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.

Medtronic Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 16th. Stockholders of record on Friday, December 26th were given a dividend of $0.71 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $2.84 annualized dividend and a dividend yield of 2.8%. Medtronic’s dividend payout ratio (DPR) is 76.55%.

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).